Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.64 |
| ▸ | RARB | P10826 | 1/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.57 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.57 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.57 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 2/20 | 0.52 |
| ▸ | HTR1B | P28222 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | DRD4 | P21917 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11068531 | 1.00 | KCNA3 (0.64) | KCNA3RARBHDAC3HDAC4HDAC1 | |
| SCHEMBL12746095 | 1.00 | KCNA3 (0.64) | KCNA3RARBHDAC3HDAC4HDAC1 | |
| SCHEMBL29394668 | 0.98 | KCNA3 (0.61) | KCNA3RARBHDAC3HDAC4HDAC1 | |
| SCHEMBL11580701 | 0.98 | KCNA3 (0.67) | KCNA3RARBHDAC3HDAC4HDAC1 | |
| Ethylene SCHEMBL28162451 | 0.96 | KCNA3 (0.59) | KCNA3RARBHDAC3HDAC4HDAC1 | |
| Ethylene Glycol SCHEMBL27943432 | 0.93 | KCNA3 (0.55) | KCNA3RARBHDAC3HDAC4HDAC1 | |
| SCHEMBL7449489 | 0.92 | KCNA3 (0.62) | KCNA3RARBHDAC3HDAC4HDAC1 | |
| Oxirane SCHEMBL8670366 | 0.91 | KCNA3 (0.53) | KCNA3RARBHDAC3HDAC4HDAC1 | |
| SCHEMBL27936313 | 0.91 | KCNA3 (0.53) | KCNA3RARBHDAC3HDAC4HDAC1 | |
| SCHEMBL11818753 | 0.91 | KCNA3 (0.53) | KCNA3RARBHDAC3HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629383-B2 | Cannabinoid compositions with high solubility and bioavailability | PISAK MEHMET NEVZAT (TR) | 2026-05-19 | — | — | US | claimed |
| US-20260016466-A1 | TEST PIECE FOR MEASURING ALBUMIN AND METHOD FOR MEASURING ALBUMIN | FUJIFILM CORPORATION (JP) | 2026-01-15 | — | — | US | claimed |
| WO-2025217418-A1 | SAMPLE PREPARATION FOR NUCLEIC ACIDS | Life Technologies Corporation (US) | 2025-10-16 | — | — | WO | claimed |
| CN-120015852-A | Preparation method of microporous layer slurry, gas diffusion layer and membrane electrode assembly | 国家电投集团氢能科技发展有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119592954-A | Aluminum etching solution and preparation method and application thereof | 湖北兴福电子材料股份有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119581579-A | Gas diffusion layer and preparation method and application thereof | 国家电投集团氢能科技发展有限公司 | 2025-03-07 | — | — | CN | claimed |
| WO-2024195780-A1 | ALBUMIN MEASUREMENT TEST PIECE AND ALBUMIN MEASUREMENT METHOD | 富士フイルム株式会社 | 2024-09-26 | — | — | WO | claimed |
| EP-4178551-B1 | CURCUMINOID COMPOSITIONS WITH HIGH BIOAVAILABILITY | PISAK MEHMET NEVZAT (TR) | 2024-08-07 | — | — | EP | claimed |
| CN-116889871-B | Titanium-loaded catalyst activated carbon with lasting strong pollution cleaning and preparation method thereof | 广东韩研活性炭科技股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117117209-B | Gas diffusion layer and preparation method and application thereof | 国家电投集团氢能科技发展有限公司 | 2024-02-09 | — | — | CN | claimed |
| EP-1290158-A2 | PROCESSING OF PLASMID-CONTAINING FLUIDS | Pall Corporation (US) | 2003-03-12 | — | — | EP | claimed |
| US-6478881-B2 | CONTAINING WATER SOLUBLE ANIONIC POLYMER | VISTA SCIENTIFIC L.L.C. | 2002-11-12 | — | — | US | claimed |
| WO-2001094573-A2 | PROCESSING OF PLASMID-CONTAINING FLUIDS | PALL CORPORATION (US) | 2001-12-13 | — | — | WO | claimed |
| US-20010020000-A1 | Contact lens cleaning solution | ELLIS JEANNE Y (US) | 2001-09-06 | — | — | US | claimed |
| US-6120794-A | OIL IN WATER EMULSION | UNIVERSITY OF PITTSBURGH (US) | 2000-09-19 | — | — | US | claimed |
| US-5981736-A | HOUSING WITH ADSORPTIVE MEDIA PACKED ON SIZE EXCLUSION MEDIA PACKED ON POROUS MEDIA; FOR CHROMATOGRAPHY AND ELUTION OF BIOLOGICAL MATERIAL IN APPROPRIATE BUFFER FOR FURTHER USE SUCH AS GENE TRANSFECTION OR ELECTROPHORESIS ANALYSIS | LIFE TECHNOLOGIES, INC. (US) | 1999-11-09 | — | — | US | claimed |
| EP-0383163-B1 | PROCESS FOR THE STIMULATION OF OIL AND GAS PROBES IN THE RECOVERY OF OIL AND GAS FROM SUBSTERRANEAN FORMATIONS, AND STIMULATION AGENTS THEREFOR | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-04-22 | — | — | EP | claimed |
| EP-0470192-A4 | IMPROVED IMMUNOASSAY INCLUDING LYOPHILIZED REACTANT MIXTURE | — | 1992-03-11 | — | — | EP | claimed |
| EP-0470192-A1 | IMPROVED IMMUNOASSAY INCLUDING LYOPHILIZED REACTANT MIXTURE. | HYGEIA SCIENCES LTD (US) | 1992-02-12 | — | — | EP | claimed |
| WO-1990013637-A1 | IMPROVED IMMUNOASSAY INCLUDING LYOPHILIZED REACTANT MIXTURE | HYGEIA SCIENCES, INC. (US) | 1990-11-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260016466-A1 | TEST PIECE FOR MEASURING ALBUMIN AND METHOD FOR MEASURING ALBUMIN | ALB, S100P, MB | KCNA3 4137/4885RARB 2282/4885HDAC3 4860/4885 |
| US-12629383-B2 | Cannabinoid compositions with high solubility and bioavailability | CNR1, GPR55, CNR2 | KCNA3 3701/4885RARB 1002/4885HDAC3 523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.